-

KBRA Europe Releases Project Finance and Infrastructure: European and UK 2022 Outlook

DUBLIN--(BUSINESS WIRE)--KBRA Europe (KBRA) releases its 2022 outlook for the European and UK project finance and infrastructure (PF&I) sector, and examines certain emerging themes to likely take centre stage in 2022. While the rollout of transactions in new PF&I sectors is attracting private placement and capital market interest, their development will face challenges, including not currently reaching the scale demanded by market participants.

Key Takeaways:

  • Renewable energy finance (both traditional and newer technologies), telecommunications, accommodation infrastructure, and transport esoteric asset classes are likely to represent the main areas of growth in 2022.
  • Transaction size, underlying market (price and volume) risk, and obsolescence may crimp bankability for newer asset classes.
  • Rising inflation, commodity volatility, and recovery from COVID-19 will have varying impact on the PF&I sector in 2022.

Click here to view the report.

Related Publications

About KBRA

KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Contacts

Gordon Kerr, Head of European Research
+44 208 148 1020
gordon.kerr@kbra.com

Karim Nassif, Project Finance & Infrastructure
+353 1 588 1245
karim.nassif@kbra.com

Garret Tynan, European Head Project Finance & Infrastructure
+353 1 588 1235
garret.tynan@kbra.com

Andrew Giudici, Global Head of Corporate, Project, and Infrastructure Finance
+1 (646) 731-2372
andrew.giudici@kbra.com

Business Development Contacts

Mauricio Noe, Co-Head of Europe
+44 208 148 1010
mauricio.noe@kbra.com

Miten Amin, Managing Director
+44 208 148 1002
miten.amin@kbra.com

Kroll Bond Rating Agency, LLC

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Gordon Kerr, Head of European Research
+44 208 148 1020
gordon.kerr@kbra.com

Karim Nassif, Project Finance & Infrastructure
+353 1 588 1245
karim.nassif@kbra.com

Garret Tynan, European Head Project Finance & Infrastructure
+353 1 588 1235
garret.tynan@kbra.com

Andrew Giudici, Global Head of Corporate, Project, and Infrastructure Finance
+1 (646) 731-2372
andrew.giudici@kbra.com

Business Development Contacts

Mauricio Noe, Co-Head of Europe
+44 208 148 1010
mauricio.noe@kbra.com

Miten Amin, Managing Director
+44 208 148 1002
miten.amin@kbra.com

More News From Kroll Bond Rating Agency, LLC

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom